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Abstract
Keratoconus, historically viewed as a non-inflammatory disease, is an ectatic corneal disorder associated with progressive
thinning of the corneal stroma. Recently, a few inflammatory mediators have been reported to be elevated in the tear fluid
of keratoconus patients. Consequently, we investigated a wide range of inflammation regulating cytokines in the tears and
sera of keratoconus and control subjects. Interleukin (IL)-1b, IL-4, IL-6, IL-10, IL-12, IL-13, IL-17, interferon (IFN)-c, chemokine
C-C motif ligand 5 (CCL5) and tumor necrosis factor (TNF)-a were tested in tear samples and sera of keratoconus and control
individuals by multiplex immuno-bead assays. Selected cytokines were further tested by standard ELISA on pooled tear
samples. All cytokines in the sera were generally low, with no significant changes between keratoconus and control
subjects. However, in tear fluids, clear differences were detected between the two groups. These differences include
increased IL-6, and decreased IL-12, TNF-a, IFN-c, IL-4, IL-13 and CCL5 in keratoconus compared to control tear fluids. The
decreases in IL-12, TNF-a and CCL5 were statistically significant, while the IL-13 decrease was statistically significant in the
severe keratoconus group only. IL-17 could not be detected by multiplex immuno-bead assay, but showed an increase in
keratoconus by conventional ELISA on a limited number of pooled tear samples. Our findings confirm increased IL-6, but
dispute earlier reports of increased TNF-a, and suggest a cytokine imbalance in keratoconus disrupting corneal homeostasis.
Moreover, an increase in IL-17 suggests tissue degenerative processes at work, contributing to the thinning and weakening
of the corneal connective tissue in keratoconus.
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Introduction
Keratoconus is an ectatic corneal disease associated with
progressive thinning of the corneal stroma, and a protruding,
cone-shaped cornea that produces astigmatism and myopia.
Keratoconus is a leading cause of corneal transplantation, affecting
1 in 2000 individuals with a mean age of onset at 15.4 years
[1,2,3,4]. The disorder typically progresses until the third to fourth
decade of life [3], and the factors that determine the progression or
stabilization of the disease are not well characterized or
understood.
Although the etiology of keratoconus is poorly understood, it is
traditionally viewed as a non-inflammatory corneal thinning disease
[1]. Accordingly, cellular infiltration and vascularization are not
clinically apparent in keratoconus. However, keratoconus has been
linked to atopy since the 1950s [5], with further support coming
from later studies that reported elevated levels of immunoglobulin
(Ig) E in the sera of keratoconus patients [6,7]. Recent studies have
suggested pro-inflammatory factors as key to keratoconus patho-
genesis based on their findings of elevated interleukin (IL)-6, tumor
necrosis factor (TNF)-a and matrix metalloproteinase (MMP)-9 in
the tear fluid of keratoconus patients [8,9]. Moreover, increased
binding of IL-1 by keratoconus corneal fibroblasts has led another
group to suggest a role for inflammation in the onset or progression
of keratoconus as well [10].
Despite these initial findings of specific changes in inflammatory
cytokines, there are no studies that have examined a range of
cytokines to determine whether keratoconus is associated with an
imbalance in the repertoire of cytokines that regulate inflamma-
tory and immune responses driven by subsets of T-helper cells,
TH1, TH2, and TH17 in the corneal environment. To begin
addressing this question, we quantified TH1 cytokines (IL-12, IFN-
c and TNF-a), TH2 cytokines (IL-4, IL-10 and IL-13), the TH17
representative cytokine IL-17, and other inflammatory cytokines/
chemokines (IL-1b, IL-6, and RANTES or CCL5) in tear fluids
and serum samples of keratoconus patients and control subjects.
Although this initial study is based on a relatively small sample
size, decreases in specific cytokines suggest down regulations of
both pro-inflammatory and immunoprotective responses to play a
role in this disease.
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Demographics
A set of 18 keratoconus (KC) and 11 controls were used for the
multiplex cytokine analyses on tear fluids and sera (Table 1). Two
(11%) of the KC patients were graded as mild (steepest K,45D), 6
(33%) as moderate (45D #steepest K#52D), and 10 (56%) as
severe (steepest K.52D). Using the Mann-Whitney test, there was
a statistically significant (p=0.02), 10 year difference in the mean
age between the controls and the keratoconus subjects, who were
on average 33 and 43 years old, respectively. Nine of the KC and
four of the control subjects wore contact lenses. Due to their
disease status, keratoconus patients normally wear hard contact
lenses, while unaffected subjects wear soft contact lenses. Although
matching by contact lens use would not per se remove this
difference, to determine if contact lens use had an effect,
irrespective of disease status, we fit a multivariate linear model
to determine the effects of contact lens wear on tear fluid cytokine
levels after adjusting for the age of the subjects. Levels of all
cytokines tested were higher in the 13 contact lens users when
compared to non-contact lens users, and while the differences were
moderate for some of the cytokines, they were not statistically
significant except for IL-4 (Table S1). The average time since
diagnosis of keratoconus was 16614 (mean 6 SD) years (Table 1).
Three of the 18 keratoconus patients had a medical history
including atopy. Tear fluid samples were collected between 9 am
and 4 pm, with no statistically significant differences in collection
times between control and keratoconus subjects. We also noted
Table 1. Keratoconus and control samples for immuno-bead multiplex ELISA.
Sample Age Gender Contact lens Diagnosis
Number Group Severity (years) (M/F) Race use (years) (years)
1 KC Severe 42 M Black None ?
2 KC Severe 44 F Native American 30.0 32
3 KC Mild 52 F White Intolerant ?
4 KC Severe 34 F White None 9
5 KC - 76 F Black 42.0 42
6 KC Mild 38 M Asian Yes 10
7 KC - 45 M White None 7
8 KC Severe 30 M Black Yes ?
9 KC Severe 31 M Native American None 3
10 KC Severe 27 M Asian None 6
11A KC Severe 27 M Native American None 10
12 KC Severe 35 M White None 9
13 KC Mild 32 F Native American 5.0 8
14A KC Mild 61 F White 20.0 25
15 KC - 61 M White None 48
16A KC Mild 40 M White 24.0 7
17 KC Mild 56 F Black Yes 22
18 KC Mild 53 M White 27.0 8
Mean 44 24.7 16
SD 14 12.2 14
1 Control N/A 22 F White 10.0 N/A
2 Control N/A 50 F White None N/A
3 Control N/A 51 M White None N/A
4 Control N/A 30 M Native American None N/A
5 Control N/A 40 M Asian None N/A
6 Control N/A 31 F White 10.0 N/A
7 Control N/A 24 M White 9.0 N/A
8 Control N/A 30 M White None N/A
9 Control N/A 31 F White None N/A
10 Control N/A 30 F White None N/A
11 Control N/A 24 F White 10.0 N/A
Mean 33 9.8
SD 10 0.5
A; atopy, KC: keratoconus, M; male, F: female, SD: 1 standard deviation, N/A: not applicable,
- Unable to obtain a keratometry measurement for severity due to irregular curvature of patient’s cornea.
doi:10.1371/journal.pone.0016437.t001
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control group. Our recent efforts are geared towards collecting
tear samples from appropriately matched control subjects, and
when applicable to collect tear fluids from the unaffected eye of
keratoconus patients as well.
A second set of samples comprising 29 KC and 38 control
samples were collected for performing individual ELISA assays for
validation purposes (Table S2). In this set, the control subjects
were matched more closely to the KC group for age and ethnicity.
The mean 6 SD ages were 38610 and 40612 years, for KC and
control subjects, respectively. Some of the KC subjects wore
contact lenses, while the control subjects for this group were not
contact lens users (Table S2). Of the keratoconus and control cases
(Table S2), atopy was reported for six and four of the individuals,
respectively.
Multiplex cytokine analysis of keratoconus and control
subjects
To investigate the relationship between disease status and
cytokine levels, we performed a linear multivariate correlation
study of natural log transformed cytokine levels and disease, after
correcting for age and contact lens use, as covariates. The results
were reported as significant in Table 2, only if disease was a
significant independent predictor of cytokine levels. All cytokines
tested by multiplex immuno-bead assay, except IL-17, were
detectable in tear samples. Table 2 shows median, 25
th and 75
th
percentile values of tear fluid cytokines of all keratoconus and
control subjects. Overall, we found IL-6 levels were 3 fold elevated
(based on mean values) in keratoconus samples compared to
control subjects (Table 2 and Figure 1), confirming a previous
report of increased IL-6 in keratoconus [8]. The increase in IL-6
did not reach statistical significance due to the variation in levels
between subjects. IL-1b was essentially unchanged, while the
remaining cytokines showed decreased levels in our keratoconus
samples. After subtracting the effects of age and contact lens use,
the decreases in TH1 related cytokines IL-12 (p=0.03), TNF-a
(p=0.04) and CCL5 (p=0.05) were statistically significant. The
decrease in TNF-a seen here, contradicts an earlier observation of
increased TNF-a in keratoconus. Statistical differences in cytokine
levels were also analyzed after stratifying the keratoconus group
into mild/moderate (steepest K#52D) and severe (steepest K.52
D) groups. No significant differences were evident when the mild
to moderate disease was compared to the controls (analysis not
shown). The comparison of the data from severe KC to that of
controls is shown in Table 3. Despite the resulting decrease in
sample size, IL-12, TNF-a and CCL5 showed even stronger
effects in severe keratoconus. The IFN-c decrease in keratoconus
compared to controls was significant by Mann-Whitney testing
(p=0.02, analysis not shown), but not by multivariate analysis,
where the large variance of the measurements appeared to
diminish its significance (Table 3). Of the TH2-related cytokines,
the decrease in IL-13 was statistically significant in severe
keratoconus versus control subjects. The multiplex immuno-bead
assay could not detect IL-17 in control or keratoconus tear
samples. Atopy was not considered as a testable variable since it
was detected in similar numbers in keratoconus and control
individuals. We found no correlation (Methods) between the time
of tear fluid collection and cytokine levels (not shown).
In the sera, there were no statistically significant differences
between keratoconus patients and control subjects for the
cytokines tested (Table 4). IL-10, IL-12 and IL-13 could not be
detected in any of the sera tested, while IL-1b, IL-4, IL-6 and
TNF-a were present at very low levels, and CCL5 was clearly
detected. Thus, the cytokine changes detected in the tear film are
likely a reflection of localized events in the eye and not systemic
changes.
Measurements of selected cytokines in tear fluid by
standard ELISA
The multiplex data implicate reductions in TH1 (IL-12, TNF-a,
IFN-c), and possibly TH2 cytokines (IL-4 and IL-13) in
keratoconus. To further explore these possibilities, we performed
standard individual ELISAs for selected cytokines. In general, the
conventional, standard ELISA (high sensitivity) is less sensitive
than multiplex immuno-bead assays. Therefore, it was necessary
to pool the tear samples from different KC and control subjects
(Table S2) for these ELISA experiments. Based on the commercial
availability of high sensitivity ELISA kits, we selected TNF-a and
IFN-c as TH1, IL-4 as TH2 and IL-17 as TH17 representative
cytokines. We found the sensitivity of the TNF-a kit to be too low
Table 2. Tear-fluid cytokine concentrations in keratoconus and control subjects.
Control (C) Keratoconus (KC) Fold
Median, quartiles
a Mean ± SD Median, quartiles
a Mean ± SD change p –
Cytokine pg/ml pg/ml pg/ml pg/ml KC/C
b value
c
IL-1b 10 [3.2, 19.4] 9.667.9 6.9 [3.6, 9.6] 8.366.7 0.88 0.87
IL-4 111.2 [52.6, 175.1] 116.1681.9 38.7 [12.8, 122.7] 69.6670.7 0.6 0.43
IL-6 66.8 [27.4, 140.4] 89.5683.5 72.2 [48.9, 241] 282.76467.7 3.2 0.17
IL-10 10.6 [0.7, 19.1] 16.5623.5 4 [0.9, 12.1] 6.967.3 0.4 0.4
IL-12 48.6 [10.6, 142.8] 89.86115.8 8.4 [1.6, 37.1] 21.8626.6 0.24 0.03
IL-13 14.7 [9.1, 46] 32.3633.5 7.8 [5.7, 12.1] 11.265.9 0.35 0.11
IFN-c 1969 [643, 4859] 278362778.7 76 [19.3, 401.6] 557.161004.3 0.2 0.2
CCL5 109.4 [57, 222] 111.3686.3 1.2 [1.2, 131.7] 59.4668.9 0.53 0.05




bfold change in mean values.
cp value based on a multivariate linear model after correcting for age and contact lens use covariates.
doi:10.1371/journal.pone.0016437.t002
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IFN-c was detectable and showed a decrease in keratoconus
compared to pooled control samples but without statistical
significance (p=0.5, data not shown). We detected 14.26
8.6 pg/ml (mean 6 SD) of IL-4 in the control and 7.665 pg/
ml in the KC pool (Figure 2); the IL-4 decrease in KC was
statistically significant (p=0.04), confirming the multiplex im-
muno-bead assay results (Figure 1, Tables 2 and 3). IL-17 was
detectable in one control and 3 keratoconus pools in one
experimental set. All negative values in that set, being below the
level of detection, were set at the minimum detection level for this
ELISA kit. Based on these limited data (Figure 3), there was a
trend towards increased IL-17 (72.5659.2 pg/ml) in keratoconus
tear fluids compared to control samples (18.567.8 pg/ml).
Discussion
In this study, we investigated cytokines in the sera and tear fluids
of keratoconus and control individuals to determine if altered
inflammatory response is a factor contributing to the etiology of
keratoconus. Of the cytokines measured in the serum, most were
at very low levels and none showed significant differences between
patients and control individuals. This is consistent with the idea
that keratoconus is not associated with major systemic inflamma-
tion. However, our results indicate perturbations in immune
related homeostasis in the tear film and the corneal microenvi-
ronment of keratoconus patients.
The published data on actual baseline cytokine concentrations
in tear fluids is limited, and quite variable. To compare our
findings to those of others, we examined the literature and found
only a few instances where tear fluids were assessed for multiple
cytokines. Since only a limited amount of tear fluid is obtainable
without stimulation, measuring multiple cytokines is challenging.
Li and coworkers used a solid phase antibody protein array-based
method to estimate the relative amounts of tear fluid cytokines in
Sjo ¨gren’s syndrome, without reporting actual levels of cytokines
[11]. A recent study used an immuno-bead based multiplex system
to obtain baseline levels of 30 different cytokines and chemokines
[12]. Others have examined isolated cytokines by conventional
sandwich ELISA and reported concentrations of IL-6, TNF-a and
IL-10 in control and keratoconus subjects [8,13]. Our immuno-
bead based assay, on average showed high levels of IL-4, IL-6, IL-
Figure 1. Cytokine measurements in tear fluids by a multiplex immuno-bead assay. Each cytokine was measured in individual subjects.
The horizontal bar indicates the mean value for each group. After correcting for age and contact lens use, IL-12, TNF-a, and RANTES/CCL5 were
significantly lower in KC than in controls. Statistical analyses of the data are shown in Tables 2 and 3.
doi:10.1371/journal.pone.0016437.g001
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subjects. Our baseline findings for IL-6 and TNF-a by multiplex
assays were 5-10 times higher than the reported single ELISA
measurements. However, our assay yielded baseline ranges for IL-
10, IL-13, CCL5 and IL-6 that were within the range reported by
the recent immuno-bead based study [12]. On the other hand, our
estimates of TNF-a and IFN-c were higher, and that of IL-1b was
lower than that reported in the earlier study [12]. Since our
immuno-bead assay kit is different from that used in the other
study, some of this difference may arise from different primary and
secondary antibodies. In addition to the variation seen between
different studies, the range for each cytokine within a given study,
including ours, is very large. Some of this variability could be due
to individual-to-individual variation in cytokine levels and the
extent of tearing even though samples are collected without direct
stimulation.
Comparing tear fluid cytokines in the control and keratoconus
subjects, we noted an increase in IL-6 in keratoconus, in
agreement with earlier reports [8,13]. In addition, we identified
significant decreases in IL-12 and TNF-a. The latter observation
disagrees with an earlier report of a small increase in TNF-a of
keratoconus tear fluids. The possible reasons for this difference are,
1) use of different antibody-based assays, 2) actual TNF-a levels
detected in the other study is very close to the lower limit of TNF-a
detection by the conventional ELISA kit used in that study, and 3)
differences in patient population between the two studies. IL-12
promotes the differentiation of TH1 cells; its decrease in
keratoconus is consistent with decreases in two signature TH1
cytokines, IFN-c and TNF-a. In severe keratoconus, IL-12 and
TNF-a decreases were more pronounced and this may play a role
in increased IL-17 and associated tissue degenerative processes.
Both IL-4 and IL-13 cytokines were also reduced in keratoconus,
and the decrease in IL-4, as measured by conventional ELISA,
was statistically significant. IL-4 is a key TH2 cell differentiation
cytokine, and both IL-4 and IL-13 play crucial roles in
amplification of the TH2 response through up regulation of
STAT5, STAT6 and GATA3 transcription [14]. Thus, decreases
in IL-4 and IL-13 suggest that TH2 responses may be dampened in
keratoconus. IL-4 is associated with allergic response and
promotes the synthesis of IgE [15]. Based on the reported link
between atopy and keratoconus, it is conceivable that IL-4 levels
would be higher in the keratoconus group. However, the number
of patients with a history of atopy in our samples was extremely
low. Thus, separate from atopy, the decrease in IL-4 we see may
Table 3. Tear-fluid cytokine concentrations in severe (K.52D) keratoconus and control subjects.
Control (C) Keratoconus (KC) Fold change
Cytokine Mean ± SD, pg/ml Mean ± SD, pg/ml KC/C p
a-value
IL-1b 12.19611.56 7.4665.58 0.61 0.83
IL-4 116681.8 33.48649.74 0.3 0.31
IL-6 89.64683.36 2546312.41 2.83 0.27
IL-10 16.46623.5 7.0569 0.41 0.17
IL-12 90.16115.57 12.57615.25 0.14 0.007
IL-13 32.34635.1 8.7966 0.27 0.04
IFN-c 2780.662781.3 543.836946.28 0.2 0.133
CCL5 1496149.4 25.8648.1 0.18 0.013
TNF-a 2536275 55.06667.72 0.22 0.04
ap value based on a multivariate linear model after correcting for age and contact lens use covariates.
doi:10.1371/journal.pone.0016437.t003
Table 4. Serum cytokine concentrations in keratoconus and control subjects.
Control (C) Keratoconus (KC) Fold change
Cytokine Mean ± SD, pg/ml Mean ± SD, pg/ml KC/C
a p
b-value
IL-1b 0.1860.15 0.1460.11 0.8 0.71
IL-4 0.0960.06 0.1160.08 1.2 0.61
IL-6 1.7763.66 1.3962.37 0.8 0.31
IL-10 ND ND N/A -
IL-12 ND ND N/A -
IL-13 ND ND N/A -
IFN-c 27.4969.73 25.84625.38 0.9 0.4
CCL5 100.70655.61 93.19658.0 0.9 0.73
TNF-a 1.4661.71 1.5761.42 1.1 1.0
aFold change in mean cytokine level.
bp value based on Mann-Whitney test. ND: Not detectable. All readings were below detection levels.
N/A: not applicable.
doi:10.1371/journal.pone.0016437.t004
Tear Fluid Cytokines in Keratoconus Patients
PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e16437be pertinent to the pathophysiology of keratoconus itself. How do
our tear fluid cytokine observations in keratoconus compare to
other ocular surface diseases? A study reported increases in IL-1b,
IL-2, IL-5, IL-6, IL-12, IL-13, in seasonal allergic conjunctivitis
(SAC), vernal keratoconjunctivitis (VKC) and atopic keratocon-
junctivitis (AKC), while IL-4, IFN-c and IL-10 levels were
increased in SAC and VKC compared to controls [16]. These
observations are certainly different from the cytokine profile we see
in keratoconus. Thus, the broad decrease in inflammatory
cytokines reported in our study may indeed be keratoconus
disease-specific.
Decreased IL-4 in keratoconus may have broad immune and
non-immune consequences [17] that should be considered in the
context of corneal thinning and abnormal stromal extracellular
matrix (ECM). IL-4 and IL-4 receptor engagement through the
JAK-STAT and the IRS1/2 pathways regulate cell proliferation
and tissue homeostasis [17]. Dermal fibroblasts stimulated with IL-
4 and IL-13 up regulate production of collagens type I and III
[18]. IL-4 mediated induction of STAT-6 pathway in intrahepatic
cells has been shown to induce collagen synthesis [19]. While its
implication in hepatic disease is over-induction of STAT-6,
increased collagen, and fibrosis, reduction of normal levels of IL-
4 in the corneal environment may tip the balance toward poor
stromal keratocyte cell survival, oxidative stress, altered collagen
and ECM stability associated with keratoconus [20,21,22,23].
In vitro and in vivo studies indicate reciprocal interactions
between IFN-c and IL-17, and between IL-4 and IL-17, and that
these cytokines restrict undue amplification of the TH17 response
[24]. It is possible that in the pathogenesis of keratoconus, decrease
and dysregulation of several cytokines and growth factors
encourage aggravated TH17 response, production of metallopro-
teinases and tissue damage. Furthermore, TGF-b and IL-6 levels
regulate differentiation of Treg and TH17 subsets of T cell [25].
TGF-b members are present in all ocular tissues [26,27,28], and,
by immunohistochemistry we detected stronger immunostaining
for total TGF-b in the epithelial layer (our unpublished
observations) of keratoconus corneas. Moreover, IL-6 levels were
increased in the tear fluid of keratoconus patients as indicated in
this study and reported earlier [8]. Indeed, whether relative TGF-
b and IL-6 levels are altered sufficiently in keratoconus ocular
tissues are not known at this time. On testing IL-17 by the
multiplex immuno-bead assay, we could not detect it in the tear
fluid. However, using an IL-17 ELISA kit, we detected higher
levels of IL-17 in 3 of the five patient pools in one set of samples.
An increasing number of studies link IL-17 to autoimmune and
inflammatory diseases such as rheumatoid arthritis, lupus, asthma
and psoriasis [29]. IL-17 is produced primarily by TH17 subset T
lymphocytes, while IL-17 receptors are found in a broad array of
cell types including fibroblasts and myofibroblasts [30,31,32].
Multiple studies are beginning to link IL-17 mediated induction of
fibroblasts and myofibroblasts and the production of tissue
degrading proteases and cytokines [31,33,34,35]. Recent studies
have also linked IL-17A to ocular pathogenesis of Sjo ¨gren’s
Syndrome [36]. Desiccating stress in dry eye disease appears to
also involve increased MMP-9 and TH17 inflammation
[37,38,39]. In dry eye, IL-17 promoting cytokines have been
shown to be produced by isolated T cells in the conjunctiva and
the cornea [37]. In our hands quantitative reverse transcriptase
polymerase chain reaction on total RNA from scraped corneal
epithelium failed to detect IL-17A. Additional immunohistology of
conjunctiva impressions will be needed to further address the
source of IL-17 producing cells and the validity of an IL-17
mediated inflammation and tissue damage in keratoconus. Two
recent studies performed proteomic analyses on the tear fluids of
unaffected individuals and keratoconus patients. In one the
authors reported down regulations in lactoferrin and immuno-
globulin kappa chains [40]. Using a cytokine antibody array, the
second study [41] found a decrease in TNF-a in agreement with
our findings here. This study reported a slight increase in TGF-b2
and b3, which would conform to our speculation that conditions in
keratoconus may favor aggravated Th17 response.
In summary, keratoconus is a complex heterogeneous disease in
which its altered corneal structure and functions may be related to
multiple factors. Our data suggest that instead of a simple increase
in pro-inflammatory cytokines, there may be a complex imbalance
between pro-inflammatory and anti-inflammatory cytokines, and
possibly aggravated TH17 response leading to altered epithelial
and stromal functions. Clearly, it is important to confirm the
observed cytokine changes in a larger patient population. To gain
insights into the immunological processes that may contribute to
these cytokine changes it is important to track down the cellular
sources of these changes. While historically many studies have
Figure 2. Decrease in IL-4 measured by standard ELISA. Samples
shown in Table S2 were pooled into 13 control and 10 keratoconus
samples (Methods). Each ELISA value is an average of two measure-
ments. The decrease in IL-4 in the keratoconus pool (7.665 pg/ml),
compared to controls (14.268.6 pg/ml) was statistically significant
(p#0.05, Mann-Whitney test). The horizontal bar indicates the mean
value for each group.
doi:10.1371/journal.pone.0016437.g002
Figure 3. Increase in IL-17 measured by standard ELISA. Five
pools of keratoconus and control subjects (Table S2) were used. Each
ELISA value is an average of two measurements. The increase in IL-17 in
keratoconus samples (72.5659.2 pg/ml) compared to controls
(18.567.8 pg/ml), was statistically significant (p#0.05, Mann-Whitney
test). The horizontal bar indicates the mean value for each group.
doi:10.1371/journal.pone.0016437.g003
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conjunctiva and the lacrimal gland as having some paracrine
effects in this disease.
Materials and Methods
Samples
All patients and normal subjects provided written informed
consent according to a protocol used in the current study that was
approved by the Johns Hopkins Institutional Review Board.
Inclusion criterion for participation in the study was presence of
keratoconus as determined by clinical examination and corneal
modeling (Pentacam, Oculus, Lynnwood, WA). Participants
completed a comprehensive questionnaire designed to collect
information on quality of life, contact lens use, past medical
history, and family history. For the multiplex cytokine analysis
(Table 1) we used 18 patients (61% males, mean age 6 standard
deviation (SD)=43613 years) and 11 control (45% males, mean
age 6 SD=33610 years) tear samples. Whole blood was collected
for serum extraction.
Conventional ELISA (Table S2) was performed for selected
cytokines on pooled samples from an additional 29 keratoconus
patients (76% male, mean age=38610) and 38 control individ-
uals (52% male, mean age=40612). These samples were pooled
to generate 13 control and 10 keratoconus pools. The keratoconus
samples were pooled based on disease status (mild, moderate and
severe).
Severity of keratoconus was graded by the steepest keratometry
(K) measurement with ,45 diopters (D) being mild, 45#K#52D
being moderate, and severe .52D or not measurable. Ophthalmic
exams consisted of best corrected visual acuity measurements, slit
lamp biomicroscopy, and corneal topography using the Pentacam.
Tear Analysis
An aliquot of 5 to 8 ml of tear fluid was collected from each eye
of participants, provided that the eye had not undergone previous
surgery. Tear samples were obtained by capillary flow using
micropipettes with care taken to minimize reactive tear produc-
tion. Samples were frozen to 280uC within one hour of collection.
Tear samples were diluted 1:25 in phosphate buffered saline
(Quality Biological, Gaithersburg, MD) containing 1 mg/ml BSA
to a final volume of 100 ml according to protocols supplied by the
multiplex immuno-bead assay kit (Human Bio-Plex suspension
array system, Biorad). The concentrations of cytokines (interleukin
(IL)-1b, IL-4, IL-6, IL-10, IL-12, IL-13, interferon (IFN)-c, tumor
necrosis factor (TNF)-a, and IL-17) and the chemokine (CC-motif)
ligand 5 (CCL5) were measured using a Bio-Plex Luminex 100
(Biorad).
Conventional enzyme-linked immunosorbent assay (ELISA)
was used to detect levels of selected cytokines in pooled tear fluid
samples diluted 1:2. The following ELISA kits were used for IFN-c
(Cat# DIF50, Human IFN-gamma Quantikine ELISA Kit, R&D
Systems), IL-4 (Cat# HS400, Human IL-4 Quantikine HS ELISA
Kit, R&D Systems) and IL-17A (Cat# D1700, human IL-17
Quantikine ELISA Kit, R&D Systems). Based on the standard
curves the detection sensitivity for IFN-c, IL-4 and IL-17 were
8 pg/ml, 0.11 and 15 pg/ml, respectively.
Serum Analysis
An aliquot of 10 ml blood was collected in a clot activating tube
(Becton Dickinson, Franklin Lakes, NJ) and allowed to stand at
room temperature one to two hours before spinning 15 minutes at
4uC. Serum aliquots were immediately transferred to 280uC for
storage. Undiluted serum samples were assayed using the Bio-Plex
Human Cytokine Assay kit, (Biorad, Hercules, CA) for IL-1b, IL-
4, IL-6, IL-10, IL-12, IL-13, IL-17, IFN-c, CCL5, TNF-a as
described for tear fluid samples.
Statistical Analysis
Chi-square tests were used to determine statistical significance
for categorical variables between groups. Cytokine levels in
keratoconus and control subjects were first compared using a 2-
tailed, Mann-Whitney nonparametric test (Prism; GraphPad
Software, San Diego, CA.), with a p-value#0.05 considered to
be statistically significant. To determine significant (p#0.05)
associations between disease status and cytokine changes, we fit
a multivariate linear model using natural log transformed cytokine
levels, with age in years, and contact lens use as covariates. These
multivariate analyses were performed using the R statistical
software (http://www.R-project.org). We found no correlation
between cytokine level and time of tear fluid collection (Spearmen
correlation, Prism; GraphPad) and did not include collection time
as a variable in the multivariate analysis.
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